An enzyme type noted in several cancers is the family of adenosine deaminases acting on RNA (ADARs). These enzymes convert ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

It blocks adenosine receptors in your brain ... Translation: you're more likely to push harder in your HIIT class or hit a PR on squats.Creatine, on the other hand, isn’t about hype—it ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year.

Eli Lilly has made a foray into the radiopharmaceuticals category with an agreement to buy POINT Biopharma for around $1.4 billion. If the $12.50-per-share all-cash deal is completed, it will give ...